Genmark Diagnostics reported $-2087000 in EBIT for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2522M 1123M
Agilent A:US $ 409M 50M
Bruker BRKR:US $ 115M 24.6M
Danaher DHR:US $ 1309M 696M
Exact Sciences EXAS:US $ -141813000 29.85M
Genmark Diagnostics GNMK:US $ -2087000 821K
Hologic HOLX:US $ 460.4M 98.2M
Illumina ILMN:US $ -479000000 666M
Laboratory Of America LH:US $ 778.6M 52.9M
Luminex LMNX:US $ 13.46M 2.96M
Mesa Laboratories MLAB:US $ 4.2M 1.08M
Myriad Genetics MYGN:US $ -79900000 60.9M
Orasure Technologies OSUR:US $ -13513000 15.09M
Oxford Immunotec Global OXFD:US 275K 10.11M
Pacific Biosciences Of California PACB:US $ -43750000 6.18M
Perkinelmer PKI:US $ 287.91M 60.24M
Quest Diagnostics DGX:US $ 665M 111M
Quidel QDEL:US $ 281.84M 257.51M
Siemens SIE:GR 1.71B 9M
Thermo Fisher Scientific TMO:US $ 2296M 56M
Veracyte VCYT:US $ -42181000 43.41M
Waters WAT:US $ 190.44M 5.98M